miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma

SIMPLE SUMMARY: MYC-driven deregulation of microRNAs represents a critical event in human malignancies, including multiple myeloma (MM). Although the introduction of new therapeutic strategies has prolonged survival of patients, MM remains an incurable disease, often due to the onset of drug resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Caracciolo, Daniele, Riillo, Caterina, Juli, Giada, Scionti, Francesca, Todoerti, Katia, Polerà, Nicoletta, Grillone, Katia, Fiorillo, Lucia, Arbitrio, Mariamena, Di Martino, Maria Teresa, Neri, Antonino, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431372/
https://www.ncbi.nlm.nih.gov/pubmed/34503175
http://dx.doi.org/10.3390/cancers13174365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431372/
https://www.ncbi.nlm.nih.gov/pubmed/34503175
http://dx.doi.org/10.3390/cancers13174365

Ejemplares similares